- About
- Ecosystem
- CellTissue Bio-Bank
- Why Bio-Bank?
- HOME
- ABOUT
- RESEARCH
- INSIGHTS & HAPPENINGS
- JOIN US
- CONTACT US
-
Menu
Current surgical treatments for major skin loss, split skin grafting (SSG) and cadaveric skin transplant are limited due to the lack of organ donors and is further limited to certain cases. CellTissue, with our pioneering expertise in Tissue Engineering, introduced a new clinical product to address these issues; the autologous Tissue Engineered Human Skin (a TEHS) and the heterologous Tissue Engineered Human Skin (hTEHS).
Tissue Engineered Human Skin is derived from the cultured skin cells of a recipient; once implanted, it will grow as part of the body
Tissue Engineered Human Skin faces little to no risk of rejection as it is autologous
Tissue Engineered Human Skin permanently closes the wound, therefore preventing infections
Tissue Engineered Human Skin can be used in the treatment of chronic and non-healing wound
Tissue Engineered Human Skin is constructed using cultured healthy and viablecells promoting better outcomes for wound healing
The aTEHS is a self-derived engineered human skin constructed using your own cells, for implantation when you experience major skin loss due to burns, traumatic injuries or diabetic ulcers. When implanted, the aTEHS mimics your native skin, vastly improving your healing time and eliminating the risks of your body rejecting the product due to it being constructed from you. Furthermore, the aTEHS can be constructed as needed, overcoming the problems of insufficient organ donations as well as reducing treatment waiting times.
The hTEHS can also be constructed for the treatment of your loved one. As the product is constructed with your cells, your family members enjoy the benefit of reduced waiting time for graft treatments, should the need arises. The use of hTEHS, donor skin grafts can promote re-epithelization, shorten healing time, alleviate pain and protect dermal and subcutaneous structures such as cartilage, tendons, bones and nerves from bacterial infections.
Founded in 2010, Cell Tissue Group is a pioneering Malaysian medical technology company and a spin-off from the National University of Malaysia (UKM). As Malaysia’s first Tissue Engineering firm, Cell Tissue Group operates within a certified cGMP laboratory, ensuring the highest standards of medical research and product development, particularly in Tissue Engineering and Regenerative Medicine.
Founded in 2010, Cell Tissue Group is a pioneering Malaysian medical technology company and a spin-off from the National University of Malaysia (UKM). As Malaysia’s first Tissue Engineering firm, Cell Tissue Group operates within a certified cGMP laboratory, ensuring the highest standards of medical research and product development, particularly in Tissue Engineering and Regenerative Medicine.
Proudly powered by CTG © 2010-2024 Cell Tissue Group, a Universiti Kebangsaan Malaysia Spin-Off Company. – All Rights Reserved.